Bovine adrenal glomerulosa cells express such a low level of functional B2 receptors that bradykinin does not significantly increase their aldosterone production

被引:9
作者
Chrétien, L [1 ]
Richard, DE [1 ]
Poirier, SN [1 ]
Poitras, M [1 ]
Guillemette, G [1 ]
机构
[1] Univ Sherbrooke, Dept Pharmacol, Fac Med, Quebec City, PQ J1H 5N4, Canada
关键词
D O I
10.1677/joe.0.1560449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It was recently demonstrated that bradykinin (BK) stimulates aldosterone secretion in bovine adrenal glomerulosa (BAG) cells, The aim of the present study was to characterize the mechanism of action of BK on these cells, Binding experiments with the radioligand I-125-[Tyr(8)]BK revealed the presence of a relatively small amount (B-max = 180 +/- 55 fmol/mg of protein) of high affinity (K-d = 0.65 +/- 0.17 nM) binding sites. BK induced a time- and concentration-dependent increase of [H-3]inositol trisphosphate ([H-3]IP3) in myo-[H-3]inositol-labeled BAG cells. A maximal response was obtained with 10 nM BK and the EC50 value was 1.0 +/- 0.5 nM. I-125-[Tyr(8)]BK binding and BK-induced IP3 production were inhibited by the selective B-2 receptor-antagonist Icatibant (1 mu M) and unaffected by the selective B-1 receptor antagonist [DesArg(9),Leu(8)]BK (1 mu M). In fura-2 loaded BAG cells, BK (100 nM) induced a typical biphasic Ca2+ response composed of a rapid and transient increase of intracellular Ca2+ concentration [Ca2+](i) which slowly declined to a level that remained above basal level for about 5 min, In the presence of EGTA (2 mM), the rapid and transient calcium increase was unaffected whereas the plateau phase was abolished. Angiotensin II (Ang II, 100 nM) also elicited a typical biphasic response in BAG cells. However the rapid and transient elevation of [Ca2+](i) was followed by a sustained plateau phase which remained above the basal level for more than 10 min. Although BAG cells ex-press functional B-2 receptors, no secretion aldosterone was observed after stimulation with 100 nM BK for 120 min. Under the same conditions Ang II increased by about 10-fold the basal level of aldosterone. The lack of effect of BK is probably attributable to its very transient effect on IP3 production. Pretreatment of BAG cells with 100 nM BK for 20 min reduced by 70 +/- 10% their total binding capacity. These results suggest a rapid and very efficient desensitization process, We conclude that BAG cells express functional B-2 receptors. The weak production of second messengers and the rapid desensitization process could explain why BK fails to increase aldosterone production in these cells. Since functional B-2 receptors are expressed in BAG cells it is likely that under some specific physiological or pathological conditions these receptors may play a significant role in aldosterone secretion, However these conditions remain to be determined.
引用
收藏
页码:449 / 460
页数:12
相关论文
共 51 条
[1]  
BALLA T, 1988, J BIOL CHEM, V263, P4083
[2]   BRADYKININ STIMULATES PRODUCTION OF INOSITOL (1,4,5) TRISPHOSPHATE IN CULTURED MESANGIAL CELLS OF THE RAT VIA A BK2-KININ RECEPTOR [J].
BASCANDS, JL ;
EMOND, C ;
PECHER, C ;
REGOLI, D ;
GIROLAMI, JP .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (04) :962-966
[3]  
BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cellbio.4.1.405
[4]   INOSITOL TRISPHOSPHATE AND CALCIUM SIGNALING [J].
BERRIDGE, MJ .
NATURE, 1993, 361 (6410) :315-325
[5]   CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES [J].
BERRIDGE, MJ ;
DAWSON, RMC ;
DOWNES, CP ;
HESLOP, JP ;
IRVINE, RF .
BIOCHEMICAL JOURNAL, 1983, 212 (02) :473-482
[6]  
BHOOLA KD, 1992, PHARMACOL REV, V44, P1
[7]   IMPLICATION OF PHOSPHOLIPASE-C IN THE STEROIDOGENIC ACTION OF ANGIOTENSIN-II [J].
BOULAY, G ;
GALLOPAYET, N ;
GUILLEMETTE, G .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 189 (4-5) :267-275
[8]   SHORT-TERM DESENSITIZATION OF THE ANGIOTENSIN-II RECEPTOR OF BOVINE ADRENAL GLOMERULOSA CELLS CORRESPONDS TO A SHIFT FROM A HIGH TO A LOW-AFFINITY STATE [J].
BOULAY, G ;
CHRETIEN, L ;
RICHARD, DE ;
GUILLEMETTE, G .
ENDOCRINOLOGY, 1994, 135 (05) :2130-2136
[9]  
BOULAY G, 1992, MOL PHARMACOL, V41, P809
[10]  
CONNOLLY TM, 1980, CLIN CHEM, V26, P41